T1	intervention 27 47	sentinel-node biopsy
T2	control 53 80	routine axillary dissection
T4	total-participants 375 378	516
T5	eligibility 379 475	patients with primary breast cancer in whom the tumor was less than or equal to 2 cm in diameter
T6	outcome 771 797	sentinel node was positive
T7	cv-bin-abs 801 803	83
T8	control-participants 811 814	257
T9	cv-bin-percent 858 870	32.3 percent
T10	iv-bin-abs 880 882	92
T11	intervention-participants 890 893	259
T12	iv-bin-percent 931 943	35.5 percent
T13	outcome 984 1028	overall accuracy of the sentinel-node status
T14	cv-bin-percent 1033 1045	96.9 percent
T15	outcome 1051 1062	sensitivity
T16	cv-bin-percent 1063 1075	91.2 percent
T17	outcome 1085 1096	specificity
T18	cv-bin-percent 1097 1108	100 percent
T20	outcome 1278 1314	events associated with breast cancer
T21	cv-bin-abs 1275 1277	15
T22	iv-bin-abs 1352 1354	10
T23	outcome 1473 1507	cases of overt axillary metastasis
T3	outcome 706 730	number of sentinel nodes
T19	outcome 1125 1129	pain
T24	outcome 1141 1153	arm mobility
